Benjamin B. Albright
Dartmouth College, University of Pennsylvania Health System, Duke University
Papers
3
Total Citations
151
H-Index
3
About
Benjamin B. Albright is a leading researcher in gynecologic surgery and oncology, best known for advancing evidence-based practices in minimally invasive hysterectomy. His seminal 2015 systematic review and meta-analysis of randomized trials comparing robotic versus laparoscopic hysterectomy for benign disease—cited 142 times—established a critical benchmark for surgical decision-making, demonstrating comparable outcomes and shaping clinical guidelines worldwide. Dr. Albright’s work also delves into the pathology of endometrial cancer, notably his 2018 study on free-floating tumor fragments in the fallopian tubes, which explored their association with recurrence and survival in Type I and Type II disease, offering novel insights into tumor dissemination. More recently, his 2021 investigation into out-of-network billing for hysterectomy patients highlighted significant healthcare cost disparities, underscoring his commitment to patient-centered outcomes and health policy. With a research portfolio spanning surgical innovation, oncologic risk stratification, and healthcare access, Dr. Albright’s contributions have directly influenced clinical practice and patient care, making him a respected voice in women’s health and surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3